Answers are grounded in this paper and cite their sources.
The objective of this study is to establish a polymerase chain reaction (PCR) laboratory for detection of multidrug resistance1 (MDR1) mutation in Thailand. Blood samples were collected from 67 dogs, namely 16 Collies, 9 Shetland Sheepdogs, 5 Border Collies, 6 Shih tzus, 13 German Shepherds and 18 mixed breeds. Genomic DNA was extracted and PCR was performed to amplify 341 and 577 bp fragments to detect homozygous wild-type (+/+) and homozygous mutant (-/-), respectively. For the heterozygous mutant (+/-), both PCR fragments would be presented. An analysis of DNA sequences encompassing the 4-base pair deletion in the coding region of MDR1 gene was performed to confirm different MDR1 genotypes. Nine Collies (56.2%) were heterozygous for the MDR1 mutation (carrier) and 7 dogs (43.8%) were homozygous for the mutant allele (affected). None of the studied Collies were homozygous for the normal allele (normal). One Shetland Sheepdog (11.1%) was heterozygous mutant. All the other breeds were homozygous normal. This research can be used for further studies to establish the PCR-based diagnostic test in suspected dogs.
No takes yet. Share an insight, caveat, or question.
Asawakarn et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: